Germany Launches Probe
Against Bayer Over Baycol

German prosecutors launched a probe into whether Bayer AG withdrew its cholesterol-lowering treatment Baycol soon enough after the drug was linked to 52 deaths.

The investigation comes after German health officials recently accused the company of failing to disclose troubling data about Baycol's side effects in a timely manner, a charge that Bayer steadfastly denies. In addition, prosecutors in the Cologne, Germany, district...